Cadence Pharmaceuticals, Inc. to Webcast Corporate Presentation at Two Upcoming Conferences

SAN DIEGO, April 27 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX - News), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that President and CEO Theodore Schroeder will present a corporate overview on Wednesday, May 2, 2007 at 1:45pm Eastern Time (10:45am Pacific Time) during the Deutsche Bank 32nd Annual Health Care Conference at the Mayflower Hotel in Washington, D.C.